IN2004DN03762A - - Google Patents

Download PDF

Info

Publication number
IN2004DN03762A
IN2004DN03762A IN3762DEN2004A IN2004DN03762A IN 2004DN03762 A IN2004DN03762 A IN 2004DN03762A IN 3762DEN2004 A IN3762DEN2004 A IN 3762DEN2004A IN 2004DN03762 A IN2004DN03762 A IN 2004DN03762A
Authority
IN
India
Prior art keywords
subjects
dosing
dose
post
subject
Prior art date
Application number
Other languages
English (en)
Inventor
T A Clayton
J R Everett
J C Lindon
J K Nicholson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0213786A external-priority patent/GB0213786D0/en
Priority claimed from GB0213895A external-priority patent/GB0213895D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of IN2004DN03762A publication Critical patent/IN2004DN03762A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
IN3762DEN2004 2002-06-14 2003-06-16 IN2004DN03762A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0213786A GB0213786D0 (en) 2002-06-14 2002-06-14 Metabolic phenotyping
GB0213895A GB0213895D0 (en) 2002-06-17 2002-06-17 Metabolic phenotyping

Publications (1)

Publication Number Publication Date
IN2004DN03762A true IN2004DN03762A (de) 2010-01-08

Family

ID=29738094

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3762DEN2004 IN2004DN03762A (de) 2002-06-14 2003-06-16

Country Status (15)

Country Link
US (2) US20050074745A1 (de)
EP (1) EP1540560B1 (de)
JP (1) JP4829496B2 (de)
KR (1) KR20050012281A (de)
AT (1) ATE502343T1 (de)
AU (1) AU2003232406A1 (de)
CA (1) CA2487836C (de)
DE (1) DE60336403D1 (de)
HK (1) HK1080167A1 (de)
HR (1) HRP20041174A2 (de)
IL (1) IL165329A0 (de)
IN (1) IN2004DN03762A (de)
NO (1) NO20045111L (de)
RU (1) RU2004136317A (de)
WO (1) WO2003107270A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050037515A1 (en) * 2001-04-23 2005-02-17 Nicholson Jeremy Kirk Methods for analysis of spectral data and their applications osteoporosis
US20050130321A1 (en) * 2001-04-23 2005-06-16 Nicholson Jeremy K. Methods for analysis of spectral data and their applications
CA2457432A1 (en) 2001-08-13 2003-02-27 Jan Van Der Greef Method and system for profiling biological systems
ATE502343T1 (de) 2002-06-14 2011-04-15 Pfizer Metabolische phänotypisierung
CA2536388A1 (en) * 2003-08-20 2005-03-03 Bg Medicine, Inc. Methods and systems for profiling biological systems
WO2007050940A2 (en) * 2005-10-27 2007-05-03 Brandon Horn Method for determining metabolic type
US7899625B2 (en) * 2006-07-27 2011-03-01 International Business Machines Corporation Method and system for robust classification strategy for cancer detection from mass spectrometry data
ATE536425T1 (de) * 2006-10-13 2011-12-15 Metabolon Inc Mit metabolischem alter verbundene biomarker und verfahren zur verwendung davon
US20080286774A1 (en) * 2007-05-16 2008-11-20 The Regents Of The University Of California Real-time individualized therapy evaluation
US20100273203A1 (en) * 2009-04-23 2010-10-28 Board Of Trustees Of The University Of Arkansas Methods and compositions for detecting metabolites
US8660823B2 (en) * 2009-04-26 2014-02-25 Lester F. Ludwig Nonlinear and lie algebra structural analysis system for enzyme cascades, metabolic signal transduction, signaling pathways, catalytic chemical reaction networks, and immunology
GB0912685D0 (en) 2009-07-22 2009-08-26 Imp Innovations Ltd Methods
GB0912744D0 (en) 2009-07-22 2009-08-26 Imp Innovations Ltd Methods and uses
US8410064B2 (en) * 2009-08-24 2013-04-02 The Board Of Trustees Of The University Of Arkansas Classical cannabinoid metabolites and methods of use thereof
US8883218B2 (en) * 2010-03-26 2014-11-11 The Board Of Trustees Of The University Of Arkansas Anti-cancer nanoparticle compositions and methods of use
GB201012297D0 (en) * 2010-07-22 2010-09-08 Ge Healthcare Uk Ltd A system and method for automated biological cell assay data analysis
US10161928B2 (en) * 2010-07-26 2018-12-25 Wellmetris, Llc Wellness panel
US9095598B2 (en) 2010-12-28 2015-08-04 The Board Of Trustees Of The University Of Arkansas Stilbenoid derivatives and their uses
US9535144B2 (en) 2012-06-01 2017-01-03 Liposcience, Inc. NMR quantification of TMAO
US9470771B2 (en) 2012-06-08 2016-10-18 Liposcience, Inc. NMR measurements of NMR biomarker GlycA
US9928345B2 (en) 2012-06-08 2018-03-27 Liposciences, Inc. Multiple-marker risk parameters predictive of conversion to diabetes
US9361429B2 (en) 2012-06-08 2016-06-07 Liposcience, Inc. Multi-parameter diabetes risk evaluations
RU2533846C1 (ru) * 2013-05-13 2014-11-20 Сергей Леонидович Устьянцев Способ определения энтропии в организме человека или животного
CN104215623B (zh) * 2013-05-31 2018-09-25 欧普图斯(苏州)光学纳米科技有限公司 面向多行业检测的激光拉曼光谱智能化辨识方法及***
US9953417B2 (en) 2013-10-04 2018-04-24 The University Of Manchester Biomarker method
US9519823B2 (en) * 2013-10-04 2016-12-13 The University Of Manchester Biomarker method
CN107764848A (zh) * 2016-08-18 2018-03-06 中国科学院烟台海岸带研究所 一种基于代谢组学评价石斑鱼饲料利用的方法
CN108766587B (zh) * 2018-05-11 2022-05-03 北京诺道认知医学科技有限公司 一种基于指定药物构建给药数据库的方法及装置
CN108717876B (zh) * 2018-05-11 2022-05-20 大连诺道认知医学技术有限公司 一种基于指定药物构建给药数据库的方法及装置
CN108445112B (zh) * 2018-05-29 2021-03-16 云南中烟工业有限责任公司 一种烟叶烟气中4-(n-甲基-n-亚硝胺)-1-(3-吡啶基)-丁酮的检测方法
WO2020081326A1 (en) * 2018-10-15 2020-04-23 Olaris, Inc. Spectographic metabolite-signature for identifying a subject's susceptibility to drugs
EP4042224A4 (de) * 2019-10-10 2023-11-08 Georgia Tech Research Corporation Markierungsfreie hämatologische und histopathologische analyse mittels uv-mikroskopie
EP3809118B1 (de) * 2019-10-17 2023-06-21 Evonik Operations GmbH Verfahren zur vorhersage eines eigenschaftswertes eines materials mittels hauptkomponentenanalyse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6658396B1 (en) * 1999-11-29 2003-12-02 Tang Sharon S Neural network drug dosage estimation
CA2416810A1 (en) * 2000-07-28 2002-02-07 Lion Bioscience Ag Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal
ATE502343T1 (de) 2002-06-14 2011-04-15 Pfizer Metabolische phänotypisierung

Also Published As

Publication number Publication date
ATE502343T1 (de) 2011-04-15
US20090192721A1 (en) 2009-07-30
EP1540560B1 (de) 2011-03-16
US20050074745A1 (en) 2005-04-07
HK1080167A1 (zh) 2006-04-21
WO2003107270A3 (en) 2005-04-21
EP1540560A2 (de) 2005-06-15
WO2003107270A2 (en) 2003-12-24
IL165329A0 (en) 2006-01-15
NO20045111L (no) 2005-01-12
US8577617B2 (en) 2013-11-05
DE60336403D1 (de) 2011-04-28
KR20050012281A (ko) 2005-01-31
AU2003232406A1 (en) 2003-12-31
CA2487836A1 (en) 2003-12-24
JP2005534899A (ja) 2005-11-17
RU2004136317A (ru) 2006-01-27
JP4829496B2 (ja) 2011-12-07
CA2487836C (en) 2014-12-02
HRP20041174A2 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
HK1080167A1 (zh) 代謝表型化
BRPI0507858A (pt) arrasto suave para teste de pressão de formação
Alexander et al. Variations with age in the mechanical properties of human skin in vivo.
WO2006133149A3 (en) Method for analyzing power consumption of circuit design using hardware emulation
GB2468045A (en) Method for reservoir characterization and monitoring including deep reading quad combo measurements
RU2008144430A (ru) Способ и система получения косметических средств на заказ
ATE431097T1 (de) Verfahren und vorrichtung für die analyse einer flüssigkeit
ATE509580T1 (de) Verfahren zum nachweis und zur vorhersage der ovulation und des fruchtbaren zeitraums
RU2013114331A (ru) Способы и системы для оцеки психологических характеристик
WO2007020598A3 (en) Method and apparatus featuring simple click style interactions according to a clinical task workflow
CN109918833A (zh) 一种数值模拟可信度的定量分析方法
Welty et al. Metrology for AI: From benchmarks to instruments
Désenfant et al. Road map for measurement uncertainty evaluation
BR122017010425B8 (pt) método de produzir uma medição de um analito usando uma tira de teste
GB201015230D0 (en) A method and system for managing analytical quality in networked laboratories
Klauenberg et al. Bayesian glaciological modelling to quantify uncertainties in ice core chronologies
Savić et al. Metrological traceability of a system for measuring electrodermal activity
WO2007136848A3 (en) Interactive device for monitoring and reporting glucose levels
Popescu et al. Relations between learning style and learner behavior in an educational hypermedia system: An exploratory study
Odenwald Test methods in the development of sports equipment
WO2008051660A3 (en) Apparatus and method for computer modeling chemical sensitivity of skin
WO2008157566A3 (en) Computerized evaluation of user impressions of product artifacts
Dale What is the best model for estimating joint health states utilities? Comparing the linear index model to the proportional decrement model
Walker Estimating how many observations are needed to obtain a required level of reliability
Corfield Description, dueting, seasonal variations, and individual identification of the vocalisations of the Brown Kiwi (Apteryx mantelli)